Imagion Biosystems Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IBXXF research report →
Price Chart
About the company
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer.
- CEO
- Robert Romeo Proulx
- IPO
- 2020
- Employees
- 11
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on IBXXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.16M
- P/E
- -0.44
- PEG
- -0.01
- P/S
- 0.00
- P/B
- -0.72
- EV/EBITDA
- -1.04
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 165.88%
- ROIC
- 377.36%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-8,804-100.4%
- Op Income
- $-3,583,483
- Net Income
- $-4,307,762-108.4%
- EPS
- $-0.02+66.3%
- OCF Growth
- -218.1%
- FCF Growth
- -218.1%
- 52W High
- $0.04
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.21
- RSI (14)
- 0
- Avg Volume
- 11
No earnings-call transcripts are available for IBXXF yet.
- Free Float
- 100.0%
- Shares Outstanding
- 539.94M
- Float Shares
- 539.73M
Our IBXXF coverage
Recent articles, reports, and earnings notes.
No research on IBXXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBXXF report →